Notice Number: NOT-AI-18-041

Key Dates
Release Date: June 19, 2018

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform potential applicants of a revision to the Eligible Organizations for PAR-18-335 "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)." Beginning with the July 31, 2018 application due date, the Eligible Organizations must have received no more than $8 million in total NIH grant and/or cooperative agreement direct award support in the last 5 years at the time of application submission.

The following section of PAR-18-335 has been modified.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Current language:

• Non-domestic (non-U.S.) Entities (Foreign Institutions)

Eligible organizations must be in a LMIC, as defined by The World Bank, and include research institutions in LMICs. Eligible applicant foreign institutions in LMICs are limited to those receiving NIAID grant and/or cooperative agreement funding at the time of application submission. Eligible organizations must have received less than $2.2 million in total NIH grant and/or cooperative agreement support (direct awards) in the last 5 years at the time of application submission. In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants' US host institutions are limited to US institutions that, at the time of submission, have received at least $5 million per year in total NIH research grant and/or cooperative agreement support over the last 10 years.

Revised language:

• Non-domestic (non-U.S.) Entities (Foreign Institutions)

Eligible organizations must be in a LMIC, as defined by The World Bank, and include research institutions in LMICs. Eligible applicant foreign institutions in LMICs are limited to those receiving NIAID grant and/or cooperative agreement funding at the time of application submission. Eligible organization must have received no more than $8 million in total NIAID grant and/or cooperative agreement direct award support in the last 5 years at the time of application submission. In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants' US host institutions are limited to US institutions that, at the time of submission, have received at least $5 million per year in total NIH research grant and/or cooperative agreement support over the last 10 years.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Paula S. Strickland, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 1-240-669-2922
Email: [email protected]